Medical Dermatology Specialists Phoenix

U.S. Dermatology Partners

Carcinoma

Prurigo

Hidradenitis

Basal Cell Carcinoma

Lichen Planus

Basal Cell Nevus Syndrome

Syndrome

Hidradenitis Suppurativa

Ruxolitinib

Vitamin D

Incyte

Case Comprehensive Cancer Center (Case CCC)

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

U.S. Dermatology Partners | Medical Dermatology Specialists Phoenix

Site insights

Work at this site?

Active trials

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) (TRuE-PN1)

Trial sponsors